{{Rsnum
|rsid=11675251
|Gene=ABI2
|Chromosome=2
|position=203384676
|Orientation=plus
|GMAF=0.3811
|Gene_s=ABI2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 22.0 | 53.2 | 24.8
| HCB | 59.3 | 35.6 | 5.2
| JPT | 52.7 | 42.0 | 5.4
| YRI | 79.6 | 19.0 | 1.4
| ASW | 67.9 | 32.1 | 0.0
| CHB | 59.3 | 35.6 | 5.2
| CHD | 57.8 | 35.8 | 6.4
| GIH | 14.1 | 40.4 | 45.5
| LWK | 61.5 | 34.9 | 3.7
| MEX | 30.4 | 53.6 | 16.1
| MKK | 54.2 | 38.1 | 7.7
| TSI | 19.0 | 46.0 | 35.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21862451
|Trait=None
|Title=GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors.
|RiskAllele=A
|Pval=4E-18
|OR=0.1500
|ORtxt=[0.12-0.18] SD decrease
|OA=1
}}

{{on chip | Illumina Human 1M}}